Experimentalevidence suggests that the Pro12Ala polymorphism of PPARγ2 is associated with areduced risk for ischemic stroke[52] and treatment with TZDsand 15d-PGJ2 cause neuroprotection in animal models of stroke. Here, PPARG is linked to stroke disorder.